Unknown

Dataset Information

0

Identification of HO-1 as a novel biomarker for graft acute cellular rejection and prognosis prediction after liver transplantation.


ABSTRACT: Background:Liver transplantation (LT) is the most effective treatment for patients with end-stage liver diseases, but acute rejection is still a major concern. However, the mechanisms underlying rejection remain unclear. Biomarkers are lacking for predicting rejection and long-term survival after LT. Methods:Isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomics was performed between acute cellular rejection (ACR) and non-rejection recipients. The molecular signature differences and potential biomarkers were identified by comprehensive bioinformatics. Heme oxygenase-1 (HO-1) expression and its association with clinical outcomes were investigated by tissue microarrays consisted of liver specimens from recipients with (n=80) and without ACR (n=57). Results:A total of 287 differentially expressed proteins (DEPs) were identified. Pathway analysis revealed that T/B cell activation, integrin/inflammation signaling pathway, etc. were significantly correlated with ACR. Through comprehensive bioinformatics, HO-1 was identified as a candidate potential biomarker for ACR. In tissue microarray (TMA) analysis, HO-1 expression was significantly higher in ACR group than in non-rejection group (P<0.01). Preoperative Child-Pugh and Meld scores were significantly higher in recipients with high HO-1 expression (P<0.01). In a mean 5-year follow-up, recipients with high HO-1 expression were associated with a shorter overall survival (P<0.05). Further multivariate analyses indicated that HO-1 could be an independent adverse prognostic factor for post-transplant survival (P=0.005). Conclusions:A total of 287 DEPs were identified, providing a set of targets for further research. Recipients with high preoperative HO-1 expression were associated with ACR. HO-1 may be used as a potential biomarker for predicting the development of post-transplant allograft ACR and recipient's survival.

SUBMITTER: Jia J 

PROVIDER: S-EPMC7154463 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Identification of HO-1 as a novel biomarker for graft acute cellular rejection and prognosis prediction after liver transplantation.

Jia Junjun J   Nie Yu Y   Geng Lei L   Li Jianhui J   Liu Jimin J   Peng Yifan Y   Huang Junjie J   Xie Haiyang H   Zhou Lin L   Zheng Shu-Sen SS  

Annals of translational medicine 20200301 5


<h4>Background</h4>Liver transplantation (LT) is the most effective treatment for patients with end-stage liver diseases, but acute rejection is still a major concern. However, the mechanisms underlying rejection remain unclear. Biomarkers are lacking for predicting rejection and long-term survival after LT.<h4>Methods</h4>Isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomics was performed between acute cellular rejection (ACR) and non-rejection recipients. The molecular  ...[more]

Similar Datasets

| S-EPMC5347403 | biostudies-literature
| S-EPMC9857115 | biostudies-literature
| S-EPMC7186718 | biostudies-literature
| S-EPMC4780413 | biostudies-literature
| S-EPMC5142373 | biostudies-literature
2016-06-01 | E-GEOD-70305 | biostudies-arrayexpress
| S-EPMC9203720 | biostudies-literature
2010-05-15 | E-GEOD-13440 | biostudies-arrayexpress
2016-06-01 | GSE70305 | GEO